SCHEMBL9209152

SCHEMBL9209152

O=c1c2ccccc2nc(CCc2c[nH]c3ccccc23)n1-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 3/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203141 0.89 NPC1 (0.64) CCKBR
SCHEMBL9203429 0.85 CCKBR (0.80) CCKBR
SCHEMBL21323255 0.79 NPC1 (0.76)
SCHEMBL12566777 0.77 LMNA (0.56) CCKBR
SCHEMBL29934873 0.77 CCKBR (1.00) CCKBR
SCHEMBL9002941 0.77 CCKBR (1.00) CCKBR
SCHEMBL16346179 0.76 NPC1 (0.67)
SCHEMBL28451012 0.76 MEN1 (0.78)
SCHEMBL16346218 0.74 MAPK1 (0.64)
SCHEMBL734714 0.73 NPC1 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475755-B1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof LILLY CO ELI (US) 1995-09-27 EP disclosed
US-5196427-A Gastrointestinal and central nervous system disorders; hormone inhibitors ELI LILLY AND COMPANY (US) 1993-03-23 US disclosed
EP-0475755-A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof ELI LILLY AND COMPANY (US) 1992-03-18 EP disclosed
US-5075313-A For bindign to cholecystokinin receptors ELI LILLY AND COMPANY (US) 1991-12-24 US disclosed